Manufacturer record
Regain Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Regain Laboratories (Haryana) were declared Not of Standard Quality between March 2019 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IFMI415, Frusemide Injection I.P. 2 ml (Rasix Injection) (exp Aug 2026). State Lab Karnataka (state lab) found it not of standard quality: pH? and Sterility. Listed in the June 2025 alert.
Records by type
3 records linked to Regain Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Frusemide Injection I.P. 2 ml (Rasix Injection) | Batch IFMI415Mfg Sep 2024 · Exp Aug 2026 | pH? and SterilitySterility | State Lab KarnatakaState lab | Jun 2025 |
| Gentamicin Injection IP (Gentatore Injection 80 mg/2ml) | Batch IGMG418Mfg Jul 2024 · Exp Jun 2026 | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab | Apr 2025 |
| AARDEX 4 mg/ml (Dexamethasone Sodium Phosphate Injection IP) | Batch RD-84Mfg Aug 2018 · Exp Jul 2020 | AssayAssay | CDTL MumbaiCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.